THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea · Delayed Price · Currency is KRW 4,540.00
+25.00 (0.55%)
At close: Sep 18, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Biochemical Diagnostics | 2.92B | Log In | Log In | Log In | Log In | Upgrade |
Biochemical Diagnostics Growth | -9.54% | Log In | Log In | Log In | Log In | Upgrade |
Molecular Diagnostics | 1.01B | Log In | Log In | Log In | Log In | Upgrade |
Molecular Diagnostics Growth | -40.61% | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostics | 462.86M | Log In | Log In | Log In | Log In | Upgrade |
Immunodiagnostics Growth | 11.84% | Log In | Log In | Log In | Log In | Upgrade |
Other | 255.45M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 597.20% | Log In | Log In | Log In | Log In | Upgrade |
Other | 255.45M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 597.20% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Other | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -22.54% | Log In | Log In | Log In | Log In | Upgrade |
America | 4.94B | Log In | Log In | Log In | Log In | Upgrade |
America Growth | 3986.09% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 2.10B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | -8.40% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 939.57M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 21.86% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -22.54% | Log In | Log In | Log In | Log In | Upgrade |